HEALWELL AI INC (AIDX.CA) Stock Fundamental Analysis
Canada - TSX:AIDX - CA42249X1006 - Common Stock
1.15 CAD
-0.04 (-3.36%)
AIDX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Providers & Services industry. AIDX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, AIDX is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year AIDX has reported negative net income.
In the past year AIDX has reported a negative cash flow from operations.
In the past 5 years AIDX always reported negative net income.
AIDX had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of -47.17%, AIDX is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
The Return On Equity of AIDX (-92.69%) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.17% | ||
| ROE | -92.69% | ||
| ROIC | N/A |
ROA(3y)-41.98%
ROA(5y)-31.25%
ROE(3y)-156.63%
ROE(5y)-292.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AIDX has a better Gross Margin (50.39%) than 80.00% of its industry peers.
AIDX's Gross Margin has improved in the last couple of years.
AIDX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.39% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.28%
GM growth 5Y6.15%
2. Health
2.1 Basic Checks
AIDX does not have a ROIC to compare to the WACC, probably because it is not profitable.
AIDX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AIDX has been increased compared to 5 years ago.
The debt/assets ratio for AIDX has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.77, we must say that AIDX is in the distress zone and has some risk of bankruptcy.
AIDX's Altman-Z score of 1.77 is fine compared to the rest of the industry. AIDX outperforms 66.67% of its industry peers.
AIDX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
AIDX has a Debt to Equity ratio of 0.40. This is amongst the best in the industry. AIDX outperforms 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.77 |
ROIC/WACCN/A
WACC8.09%
2.3 Liquidity
A Current Ratio of 0.79 indicates that AIDX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.79, AIDX is in line with its industry, outperforming 46.67% of the companies in the same industry.
AIDX has a Quick Ratio of 0.79. This is a bad value and indicates that AIDX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AIDX (0.79) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.79 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
AIDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.02%, which is quite impressive.
The Revenue has grown by 180.90% in the past year. This is a very strong growth!
The Revenue has been decreasing by -3.38% on average over the past years.
EPS 1Y (TTM)43.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.23%
Revenue 1Y (TTM)180.9%
Revenue growth 3Y-6.59%
Revenue growth 5Y-3.38%
Sales Q2Q%120.92%
3.2 Future
Based on estimates for the next years, AIDX will show a very strong growth in Earnings Per Share. The EPS will grow by 22.20% on average per year.
Based on estimates for the next years, AIDX will show a very strong growth in Revenue. The Revenue will grow by 56.81% on average per year.
EPS Next Y56.97%
EPS Next 2Y32.85%
EPS Next 3Y22.2%
EPS Next 5YN/A
Revenue Next Year243.72%
Revenue Next 2Y116.62%
Revenue Next 3Y73.05%
Revenue Next 5Y56.81%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AIDX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIDX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as AIDX's earnings are expected to grow with 22.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.85%
EPS Next 3Y22.2%
5. Dividend
5.1 Amount
No dividends for AIDX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:AIDX (11/14/2025, 7:00:00 PM)
1.15
-0.04 (-3.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.83%
Inst Owner ChangeN/A
Ins Owners14.26%
Ins Owner ChangeN/A
Market Cap321.51M
Revenue(TTM)100.17M
Net Income(TTM)-59.22M
Analysts83.53
Price Target3.52 (206.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.56%
Min Revenue beat(2)-25.55%
Max Revenue beat(2)-1.58%
Revenue beat(4)0
Avg Revenue beat(4)-7.67%
Min Revenue beat(4)-25.55%
Max Revenue beat(4)-0.56%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-60%
EPS NY rev (1m)0%
EPS NY rev (3m)-50%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)143.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.21 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.03 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.36
BVpS0.23
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.17% | ||
| ROE | -92.69% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.39% | ||
| FCFM | N/A |
ROA(3y)-41.98%
ROA(5y)-31.25%
ROE(3y)-156.63%
ROE(5y)-292.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.28%
GM growth 5Y6.15%
F-Score5
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 13.22% | ||
| Cap/Sales | 2.23% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.79 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 1.77 |
F-Score5
WACC8.09%
ROIC/WACCN/A
Cap/Depr(3y)14.05%
Cap/Depr(5y)20.98%
Cap/Sales(3y)2.16%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.23%
EPS Next Y56.97%
EPS Next 2Y32.85%
EPS Next 3Y22.2%
EPS Next 5YN/A
Revenue 1Y (TTM)180.9%
Revenue growth 3Y-6.59%
Revenue growth 5Y-3.38%
Sales Q2Q%120.92%
Revenue Next Year243.72%
Revenue Next 2Y116.62%
Revenue Next 3Y73.05%
Revenue Next 5Y56.81%
EBIT growth 1Y10.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year105.86%
EBIT Next 3Y39.33%
EBIT Next 5Y34.57%
FCF growth 1Y-286.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-258.83%
OCF growth 3YN/A
OCF growth 5YN/A
HEALWELL AI INC / AIDX.CA FAQ
What is the ChartMill fundamental rating of HEALWELL AI INC (AIDX.CA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to AIDX.CA.
What is the valuation status of HEALWELL AI INC (AIDX.CA) stock?
ChartMill assigns a valuation rating of 1 / 10 to HEALWELL AI INC (AIDX.CA). This can be considered as Overvalued.
What is the profitability of AIDX stock?
HEALWELL AI INC (AIDX.CA) has a profitability rating of 1 / 10.
How sustainable is the dividend of HEALWELL AI INC (AIDX.CA) stock?
The dividend rating of HEALWELL AI INC (AIDX.CA) is 0 / 10 and the dividend payout ratio is 0%.